Drug Information Association Logo
Corporate Tagline

DIA in the News

DIA brings together the world’s leading experts to discuss the most pressing issues related to medical product development. The output from these forums has resulted in the following coverage in a number of highly regarded media outlets.

EuroMeeting Report: INN Debate: IFPMA Pushes for Biosimilar Label Changes

EuroMeeting Report: Amgen Calls on Pharma to Educate Doctors on Biosimilars

EuroMeeting Report: Expert: 'We lack the regulatory models' for Next Generation Drugs

EuroMeeting Report: All Clinical Trials to be Published Under European Law

Venus bags UBM India Pharma Award for Elores

ASBM Presents New European Survey Findings on Biosimilars and the Importance of Nonproprietary Naming

Alzheimer’s Sessions at DIA 2013 focus on Challenges, Innovative Approaches in Drug Development

Combination Products: Everyone Wants to Be a Device

Theorem Clinical Research Releases the Online Version of Its Book "Smart Thinking," a Compilation of Theories by Industry Leaders

Evidence points to continuing medical value in orphan-drug industry incentives, says Makovsky Health

DIA’s 8th Annual Conference kicks-off in Bangalore

DIA 8th Annual event portrays promising prospects for clinical research industry

India to assume leadership status in clinical trials once govt accepts & implements expert panel recommendations: Prof. Ranjit Royc

Drug Information Association to Host Annual Canadian Meeting: New Realities/New Frontiers

DIA to Host 8th Annual Conference on The New Clinical Research Environment in India: Implications and Opportunities 

Drug Information Association to Host 8th Annual Conference on the New Clinical Research Environment in India: Implications and Opportunities

CMS Needs Payment Reform Ideas For Rare Diseases From Private Sector - Former Official
Permission to post this story from Pink Sheet.

Economic Research Demonstrates Continued Value in Orphan Drug Act Incentives

Will Orphan Drug Reimbursement Policies Remain Stable?

Sticker Shock: Will Orphan Drug Reimbursement Remain Stable?

Patient Advocates to Share Stories of Challenges, Hope at DIA-NORD Conference

USAe announces Barbara Lopez as Global Chief Executive

Drug Information Association to Host 10th Middle East Regulatory Conference

DIA Conference To Focus On Clinical Trial Disclosure And The Importance Of Transparency

U.S. Department of Health and Human Services Deputy Secretary to Present Keynote Address at Conference Hosted by DIA and NORD

Barbara Lopez Kunz Named DIA Global Chief Executive

No Differences in Quality of Clinical Trial Data Across Regions, Reports Drug Information Journal

DIA to Organise One-day Workshop on Imaging in Clinical Trials on July 27 in Bengaluru

Consumer Bodies Unanimously Support Implementation of System

Benchmark Initiates BioCLinica with Buy, $8 PT as Possible M&A Target

Nice Insight looks at outsourcing trends from drug developer POV

Research Study Management SaaS Offers Several Integration Tools.

Social Enterprise Compliance Software manages compliance risk.

New Mobile Healthcare Survey Reveals Mixed Bag

New Study Sponsored by Medidata Solutions Identifies Up to $5 Billion in Potential Clinical Trial Cost Savings

Clinical Trial App Could Save Time On Site Setup VideoClinical Trials Can Waste How Much Money?

FDA Commissioner: Patient Safety Must be Prioritized Over Job Creation

Supreme Court Predictions and Opinions on Disclosing Payments to Doctors

Updates from DIA 2012: “Collaborate to Innovate,” Says the Association

Drug and Food Safety Trumps Jobs, Say FDA’s Hamburg, Other Regulators

Drug Information Association Convention Here This Week

Drug Shortages are About Quality but Also About Price

Outsourcing Software for Clinical Trial Management Seeks to Cut Costs

Phlexglobal Repositions to Underline Trial Master File Expertise

Tufts Study Finds Unneeded Trial Data Being Collected

Survey: Future for Mobile Tech in Clinical Trials

Drug Information Association Gathers at Philly Convention Center

FierceBiotechIT Lands in Philly for DIA

Life Sciences Key to Philadelphia Future (Op-Ed)

Pharma Giants Seek Temps as Start-up Funding Sags